Dr. G. Vasu Babu

Education Qualifications

• 2021-2022: Assistant Professor, Medical Oncology, Tata Memorial Hospital, Mumbai
• 2018-2021: Senior Resident (DM), Medical Oncology, Tata Memorial Center, Mumbai
• 2016-2018: Fellowship in Bone Marrow Transplantation, Jaslok Hospital, Mumbai
• 2013-2016: DNB Internal Medicine, Tata Main Hospital, Jamshedpur
• 2012-2013: Compulsory Rotatory Internship, NRI Medical College, Guntur
• 2007-2012: MBBS, NRI Medical College, Guntur

Experience

• Currently working as a Consultant Medical, Hemato-Oncologist & Bone Marrow Transplant Physician at Yashoda Hospitals, Secunderabad
• Consultant Medical Oncologist and Bone Marrow Transplant Physician, HCG, Vijayawada
• Assistant Professor, Hematolymphid DMG, TMH, Mumbai
• Senior Resident, Department of Medical Oncology, TMH, Mumbai
• Fellowship in BMT, Jaslok Hospital, Mumbai

Services offered

• Chemotherapy
• Immunotherapy
• Precision Targeted Therapy
• Bone Marrow Transplantation
• CAR-T/Cellular Therapy

Special Interest and Expertise

• Leukaemia
• Lymphoma
• Myeloma
• Bone Marrow Transplantation
• CAR-T/Cellular Therapy

Professional Membership

• Society of Hematologic Oncology (SOHO)
• European Hematology Association (EHA)
• American Society of Clinical Oncology (ASCO)
• European Society of Medical Oncology (ESMO)
• Indian Society of Medical and Pediatric Oncology (ISMPO)
• American Society of Hematology (ASH)

Research & Publications

• Samanta RP, Babu GV. Mycobacterium Tuberculosis Infection at Pacemaker Implantation Site. J Assoc Physicians India. 2017;65(2):88-89.
• Goli VB, Jain R, Bhat G, Sainani A, Advani SH. Musculoskeletal chronic graft versus host disease - A rare complication of allogeneic hematopoietic stem cell transplantation: A case report and review of its literature. South Asian J Cancer. 2017;6(4):150. doi:10.4103/sajc.sajc_145_17
• Goli VB, Jain R, Bhat G, Sainani A, Advani SH. Monoclonal gammopathy in chronic lymphocytic leukemia: A case report and review of its literature. Indian J Med Paediatr Oncol Indian J Med Paediatr Oncol 2018;39:257-9.
• Bhat, Ganapathi & Goli, Vasu & Patel, Rajas & Jain, Reetu. (2017). Loss of Human Epidermal Growth Factor Receptor 2 (HER-2) Expression after Trastuzumab Treatment in Locally Advanced Breast Cancer: A Case Report. Annals of International Medical and Dental Research. 3. 10.21276/aimdr.2017.3.6.MC1.
• Goli, Vasu & Shah, Preet & Bhat, Ganapathi & Nagral, Aabha. (2019). Post‑transplant Epstein-Barr Virus‑Related Lymphoproliferative Disorder. Indian journal of medical and paediatric oncology.
• Majumdar. S, Goli VB, Thorat.J. Methotrexate leukoencephalopathy Cancer Res Stat Treat 2019;2:261-2
• Patil V, Noronha V, Dhumal SB, et al. Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial. Lancet Glob Health. 2020;8(9):e1213-e1222. doi:10.1016/S2214-109X(20)30275-8
• Laboni Sarkar, Vasu Babu Goli, Nandini Menon, Vijay Maruti Patil, Vanita Noronha, Kumar Prabhash et al. Vaccination practices, efficacy, and safety in adults with cancer: A narrative review Cancer Res Stat Treat 2021;4:505-15
• Mirgh S, Gokarn A, Punatar S, Chichra A, Singh A, Rajendra A, Vasu Babu Goli et al Clinical course of severe COVID19 treated with tocilizumab and antivirals post-allogeneic stem cell transplant with extensive chronic GVHD. Transpl Infect Dis. 2021 Aug;23(4):e13576. doi: 10.1111/tid.13576. Epub 2021 Feb 18. PMID: 33523551; PMCID: PMC7994986.
• Jain H, Sengar M, Goli VB, et al. Bortezomib and rituximab in de novo adolescent/adult CD20-positive, Ph-negative pre-B-cell acute lymphoblastic leukemia. Blood Adv. 2021;5(17):3436-3444. doi:10.1182/bloodadvances.2020003368
• Babu V, Yadav S, Thorat J, et al. Subcutaneous Panniculitis-like T-Cell Lymphoma: Clinical Features and Outcomes from a Single Tertiary Center. Indian J Hematol Blood Transfus. 2021;37(4):697-698. doi:10.1007/s12288-021-01432-x
• Mirgh SP, Gokarn A, Rajendra A, Vasu Babu Goli et al. Clinical characteristics, laboratory parameters and outcomes of COVID-19 in cancer and non-cancer patients from a tertiary cancer centre in India. Cancer Med. 2021 Dec;10(24):8777-8788. doi: 10.1002/cam4.4379. Epub 2021 Nov 16. PMID: 34786866; PMCID: PMC8646792.
• Hasmukh Jain, Akhil Rajendra, Manju Sengar, VasuBabu Goli, Jayashree Thorat, Hemanth Muthuluri, Himanshi Gupta, Neha Sharma, Thomas Eipe & Hiral Mehta (2022). The current treatment approach to adolescents and young adults with acute lymphoblastic leukemia (AYA-ALL): challenges and considerations, Expert Review of Anticancer Therapy, 22:8, 845-860, DOI: 10.1080/14737140.2022.2093718
• Noronha V, Patil V, Chaturvedi P, Mathrudev V, Menon N, Bhattacharjee A, Singh A, Peelay Z, Chakraborty S, Jadhav M, Alone M, Bhagyavant P, Kolkur M, Srinivas S, Das S, Roy S, Mandal T, Dsouza H, Saha S, Rai R, Srikanth A, Shah D, Khan A, Muthuluri H, Kumar A, Agarwal A, Rajpurohit A, Goli VB, Sekar A, Prabhash K. Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer. Eur J Cancer. 2024 Mar;200:113560. doi: 10.1016/j.ejca.2024.113560. Epub 2024 Jan 20. PMID: 38306841.
• Book Chapters:
• Chapter 3: Management of Non-Hodgkin’s Lymphoma, Springer Handbook
• Author in EBM-Chemotherapy in oncogene driver negative non-small cell lung cancer, EBM-Evidence Based Medicine TMH-2022
• Research Projects:
• MD Thesis: Dissertation submitted to the NBE. Study of serum magnesium levels in Type 2 Diabetes Mellitus
• DM Thesis: To assess the efficacy and toxicity of paclitaxel and carboplatin in neo-adjuvant setting in esophageal cancer-A retrospective study
• Awaiting IEC Approval - A phase 1 study of maintenance therapy with azacitidine and pomalidomide for adult patients with AML

Posters/papers/oral Presentations

• Poster Presentation, Bortezomib and Rituximab in de-novo adolescent/adult CD20-positive, Ph-negative pre-B-cell Acute Lymphoblastic Leukemia-3 Year Updated Results, Society of Haematologic Oncology Meeting, Sep 11-14, 2022
• Poster Presentation, Treatment patterns and outcomes in acute promyelocytic leukemia-Real world data, European Haematologic Association, Austria-Vienna, June 2021
• Poster Presentation, Case Series of Fatal Geotrichum Clavatum Blood Stream Infection in Stem Cell Transplant Recipients, Asia-Pacific Blood and Bone Marrow Transplantation Group (APBMT 2020), October 11, 2020
• Poster Presentation, Real world data on safety and efficacy of ABVD in adolescents and young adults, Society of Haematologic Oncology Meeting, Sep 11-14, 2019
• Poster Presentation, Leukemic phase, Lactic acidosis and HLH: A case report and review of literature of lethal triad, HEAMATOCON 2018
• Oral Presentation, T315I mutation status Post-Hematopoietic stem cell transplantation (HSCT) in CML and Ph positive ALL (Series of five patients and review of literature), HEAMATOCON 2018

Awards and Achievements

• EHA Young Investigator Grant, 2022
• SOHO Young Investigator Grant, 2018 and 2022
• ASH Abstract Achievement Award 2020, Bortezomib and Rituximab in de-novo adolescent/adult CD 20-positive, Ph-negative pre-B cell Acute Lymphoblastic Leukemia

  FAQ'S

1. 1. Why do patients frequently visit Dr. G. Vasu Babu?
   

   Patients visit Dr. G. Vasu Babu to receive treatment for various blood cancers.

2. 2. What is Dr. G. Vasu Babu's educational qualification?
   

   Dr. G. Vasu Babu holds the following qualifications: DNB (Medicine), DM Medical Oncology (TMH Mumbai), Fellowship in Bone Marrow Transplantation.

3. 3. What does Dr. G. Vasu Babu specialise in?
   

   Dr. G. Vasu Babu is a Consultant Medical, Hemato-Oncologist & Bone Marrow Transplant Physician who specialises in the treatment and management of all blood cancers.

4. 4. Where does Dr. G. Vasu Babu practice?
   

   Dr. G. Vasu Babu practices at Yashoda Hospitals, Secunderabad.

5. 5. How can I book Dr. G. Vasu Babu’s appointment?
   

   You can schedule an appointment with Dr. G. Vasu Babu for both an Online Video Consultation and an OPD Consultation by visiting his profile on Yashoda Hospitals.